Heterogeneity in Depression and Suicidality Risk Among Vitiligo Patients: A Meta-Analysis of Adolescent Complexity and Subgroup Stratification.

Stress HealthOct 30, 2026
Clinical ResearchDermatologyPsychiatry

Yanbin Chen, Yongyi Xie, Mingyuan Xu et al.

✦ AI-curated · Sources linked

In 30 seconds

This meta-analysis assessed depression and suicidality in people with vitiligo, drawing on 73 studies identified through searches of four databases. The pooled prevalence of depression was 0.37 (95% CI, 0.30-0.45). Compared with non-vitiligo controls, patients with vitiligo had higher odds of depression (OR = 1.60, 95% CI [1.05, 2.43]) and suicide-related outcomes (OR = 1.22, 95% CI [1.05, 1.41]); suicidal ideation showed the greatest increase (OR = 2.05, 95% CI [1.08, 3.90]). Subgroup findings varied by sex and age, and continuous depression scores were not significant after publication bias correction.

Key findings

  • Pooled depression prevalence among patients with vitiligo was 0.37 (95% CI, 0.30-0.45).
  • Compared with non-vitiligo controls, depression odds were higher (OR = 1.60, 95% CI [1.05, 2.43]), as were odds of suicide-related outcomes (OR = 1.22, 95% CI [1.05, 1.41]).
  • Suicidal ideation had the greatest reported increase versus controls (OR = 2.05, 95% CI [1.08, 3.90]).
  • Adolescents with vitiligo had higher depression risk than age-matched controls (OR = 2.84), but lower risk than adults within the vitiligo population (OR = 0.20).

Why it matters

The pooled findings indicate that depression and suicide-related outcomes are relevant components of the burden associated with vitiligo. Variation across subgroups, including the contrasting adolescent comparisons, cautions against treating risk as uniform. Awareness of these mental health associations can inform a more comprehensive understanding of patient well-being alongside the skin condition.

What to keep in mind

The meta-analysis combines studies with differing populations and reference groups; the abstract also reports that continuous depression-score findings were not significant after publication bias correction.

Source

Published in Stress Health. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Dermatology

Clinical ResearchOncology (Medical)

Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations.

This international consensus guideline addresses curative-intent management of de novo metastatic nasopharyngeal carcinoma, a population historically treated with palliative intent.

Lancet OncolOct 29, 2026Read summary
Clinical ResearchHematology

Decitabine plus busulfan-cyclophosphamide versus busulfan-cyclophosphamide myeloablative conditioning before allogeneic haematopoietic stem cell transplantation for reducing risk of relapse in adult KMT2A‑rearranged leukaemia in China: an open-label, multicentre, randomised phase 3 trial.

This open-label, multicentre, randomised phase 3 trial compared decitabine plus busulfan-cyclophosphamide (DAC-BuCy) with BuCy conditioning before allogeneic HSCT in 130 patients aged 14–65 years with KMT2A-rearranged…

Lancet HaematolOct 30, 2026Read summary
Clinical ResearchPediatrics

Prone positioning and high-frequency oscillatory ventilation in early paediatric acute respiratory distress syndrome (PROSpect): an international, two-by-two factorial, response-adaptive, phase 3, randomised controlled trial.

PROSpect was an international, two-by-two factorial, phase 3 randomised controlled trial comparing prone with supine positioning and high-frequency oscillatory ventilation (HFOV) with conventional mechanical ventilation…

LancetOct 30, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.